• Profile
Close

Usefulness of the C-reactive protein/albumin ratio for predicting no-reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

European Journal of Clinical Investigation Apr 27, 2018

Karabag Y, et al. - Authors wanted to ascertain if the C-reactive protein/albumin ratio (CAR) was associated with imperfect reperfusion, which could worsen the prognosis of ST-elevation myocardial infarction (STEMI) in patients treated with primary percutaneous coronary intervention (pPCI). Data illustrated that systemic inflammation markers such as white blood cell count (WBC), neutrophil-to-lymphocyte ratio (NLR) and CAR taken from a blood sample on admission could forecast no-reflow (NR). It was also deduced that CAR had a higher clinical value vs CRP, albumin level, WBC count and NLR in NR prediction.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay